{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:47:02Z","timestamp":1791874022096,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Unversity of Bialystok","award":["B.SUB.24.250"],"award-info":[{"award-number":["B.SUB.24.250"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Protein glycation is crucial in the pathogenesis of diabetes and its cardiovascular complications. Little is known about the antiglycation properties of amlodipine, a long-acting calcium channel blocker used to treat high blood pressure. In our study, amlodipine\u2019s antiglycoxidant activity was assayed in sugars (glucose, fructose, and ribose), aldehydes (glyoxal), and chloramine T-modified bovine serum albumin (BSA). Aminoguanidine and N-acetylcysteine were used as standard glycation\/oxidation inhibitors. The content of oxidation, glycoxidation, and glycation protein products was measured colorimetrically and fluorimetrically. A one-way analysis of variance (ANOVA) followed by Tukey\u2019s post hoc test was used for statistical analysis. The mechanism of amlodipine\u2019s antiglycoxidant activity was also evaluated using in-silico molecular docking. Amlodipine protects against BSA oxidation, as evidenced by enhanced total thiol content and mitigated protein carbonyls\/advanced oxidation protein products. Amlodipine also increased the fluorescence of tryptophan and decreased the contents of kynurenine, N-formylkynurenine, and dityrosine. In addition, amlodipine effectively prevents protein glycation, as evidenced by a reduction in amyloid-beta structure, Amadori products, and advanced glycation end products (AGEs). In in silico analysis, amlodipine\u2019s antiglycation properties were indicated during its interaction with BSA, glycosidases, and AGEs\/receptor for AGEs (RAGE) pathway proteins. Among all proteins, amlodipine docked best with c-Jun N-terminal kinases. Summarizing, we have demonstrated the anti-glycation and antioxidant activity of amlodipine <jats:italic>in vitro.<\/jats:italic> This effect may be particularly important in patients with diabetes and atherosclerosis, where excessive glycation accelerates the development of vascular complications. Further studies are needed to confirm the antidiabetic activity of amlodipine in vivo.<\/jats:p>","DOI":"10.1038\/s41598-025-18925-8","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:51:55Z","timestamp":1758887515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["In vitro and in silico studies and a systematic literature review of antiglycation properties of amlodipine"],"prefix":"10.1038","volume":"15","author":[{"given":"Karolina","family":"Da\u0144kowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz","family":"Nesterowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil Klaudiusz","family":"Lauko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Trocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"\u017bendzian-Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy Robert","family":"\u0141adny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zalewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"\u017bebrowska-Gamdzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Maciejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"18925_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario, K., Okura, A., Hoshide, S. & Mogi, M. The WHO global report 2023 on hypertension warning the emerging hypertension burden in Globe and its treatment strategy. Hypertens. Res. 47, 1099\u20131102 (2024).","journal-title":"Hypertens. Res."},{"key":"18925_CR2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cpcardiol.2007.01.002","volume":"32","author":"WJ Elliott","year":"2007","unstructured":"Elliott, W. J. Systemic hypertension. Curr. Probl. Cardiol. 32, 201\u2013259 (2007).","journal-title":"Curr. Probl. Cardiol."},{"key":"18925_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/5584_2016_99","volume":"956","author":"Y Kokubo","year":"2017","unstructured":"Kokubo, Y. & Matsumoto, C. Hypertension is a risk factor for several types of heart disease: review of prospective studies. Adv. Exp. Med. Biol. 956, 419\u2013426 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"18925_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/jch.12638","volume":"18","author":"MJ Cryer","year":"2016","unstructured":"Cryer, M. J., Horani, T. & DiPette, D. J. Diabetes and hypertension: A comparative review of current guidelines. J. Clin. Hypertens. (Greenwich). 18, 95\u2013100 (2016).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"18925_CR5","doi-asserted-by":"publisher","first-page":"1128872","DOI":"10.3389\/fphar.2023.1128872","volume":"14","author":"K Taguchi","year":"2023","unstructured":"Taguchi, K. & Fukami, K. RAGE signaling regulates the progression of diabetic complications. Front. Pharmacol. 14, 1128872 (2023).","journal-title":"Front. Pharmacol."},{"key":"18925_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.expneurol.2004.10.011","volume":"191","author":"X Zhang","year":"2005","unstructured":"Zhang, X., Dong, F., Ren, J., Driscoll, M. J. & Culver, B. High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp. Neurol. 191, 318\u2013325 (2005).","journal-title":"Exp. Neurol."},{"key":"18925_CR7","doi-asserted-by":"crossref","unstructured":"Masenga, S. K., Kabwe, L. S., Chakulya, M. & Kirabo, A. Mechanisms of oxidative stress in metabolic syndrome. Int J. Mol. Sci 24, (2023).","DOI":"10.3390\/ijms24097898"},{"key":"18925_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41440-018-0034-4","volume":"41","author":"M Ohishi","year":"2018","unstructured":"Ohishi, M. Hypertension with diabetes mellitus: physiology and pathology. Hypertens. Res. 41, 389\u2013393 (2018).","journal-title":"Hypertens. Res."},{"key":"18925_CR9","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3390\/nu11030532","volume":"11","author":"RK Perkins","year":"2019","unstructured":"Perkins, R. K. et al. Experimental hyperglycemia alters Circulating concentrations and renal clearance of oxidative and advanced glycation end products in healthy obese humans. Nutrients 11, 532 (2019).","journal-title":"Nutrients"},{"key":"18925_CR10","doi-asserted-by":"publisher","first-page":"17498","DOI":"10.1038\/s41598-023-44617-2","volume":"13","author":"SA Abdelhady","year":"2023","unstructured":"Abdelhady, S. A. et al. The suppression of MAPK\/NOX\/MMP signaling prompts renoprotection conferred by prenatal Naproxen in weaning preeclamptic rats. Sci. Rep. 13, 17498 (2023).","journal-title":"Sci. Rep."},{"key":"18925_CR11","doi-asserted-by":"crossref","unstructured":"Shi, P. et al. Low bone turnover is associated with advanced glycation end-products, oxidative stress, and inflammation induced by type 2 diabetes mellitus. FASEB J 38, (2024).","DOI":"10.1096\/fj.202400790R"},{"key":"18925_CR12","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/biomedicines12081737","volume":"12","author":"B Ana","year":"2024","unstructured":"Ana, B. Aged-Related changes in microglia and neurodegenerative diseases: exploring the connection. Biomedicines 12, 1737 (2024).","journal-title":"Biomedicines"},{"key":"18925_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab, Z. Role of advanced glycation end products in cardiovascular disease. World J. Cardiol. 4, 90 (2012).","journal-title":"World J. Cardiol."},{"key":"18925_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.molmet.2013.11.006","volume":"3","author":"A Stirban","year":"2014","unstructured":"Stirban, A., Gawlowski, T. & Roden, M. Vascular effects of advanced glycation endproducts: clinical effects and molecular mechanisms. Mol. Metab. 3, 94\u2013108 (2014).","journal-title":"Mol. Metab."},{"key":"18925_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jch.14709","volume":"25","author":"JG Wang","year":"2023","unstructured":"Wang, J. G., Palmer, B. F., Anderson, V., Sever, P. & K. & Amlodipine in the current management of hypertension. J. Clin. Hypertens. (Greenwich). 25, 801\u2013807 (2023).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"Suppl 5","key":"18925_CR16","first-page":"S15","volume":"67","author":"NM Kaplan","year":"1991","unstructured":"Kaplan, N. M. Amlodipine in the treatment of hypertension. Postgrad. Med. J. 67 (Suppl 5), S15\u2013S19 (1991).","journal-title":"Postgrad. Med. J."},{"key":"18925_CR17","doi-asserted-by":"crossref","first-page":"III3","DOI":"10.1002\/clc.4960170103","volume":"17","author":"PA van Zwieten","year":"1994","unstructured":"van Zwieten, P. A. Amlodipine: an overview of its pharmacodynamic and Pharmacokinetic properties. Clin. Cardiol. 17, III3\u20136 (1994).","journal-title":"Clin. Cardiol."},{"key":"18925_CR18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2337\/diacare.24.6.1069","volume":"24","author":"RJ Anderson","year":"2001","unstructured":"Anderson, R. J., Freedland, K. E., Clouse, R. E. & Lustman, P. J. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 24, 1069\u20131078 (2001).","journal-title":"Diabetes Care"},{"key":"18925_CR19","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey, R. M., Moran, A. E. & Whelton, P. K. Treatment of hypertension: A review. JAMA 328, 1849\u20131861 (2022).","journal-title":"JAMA"},{"key":"18925_CR20","first-page":"64","volume":"66","author":"M Tiwaskar","year":"2018","unstructured":"Tiwaskar, M., Langote, A., Kashyap, R. & Toppo, A. Amlodipine in the era of new generation calcium channel blockers. J. Assoc. Physicians India. 66, 64\u201369 (2018).","journal-title":"J. Assoc. Physicians India"},{"key":"18925_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3904\/kjim.2017.153","volume":"32","author":"JS Moon","year":"2017","unstructured":"Moon, J. S. & Won, K. C. Oxidative stress: link between hypertension and diabetes. Korean J. Intern. Med. 32, 439\u2013441 (2017).","journal-title":"Korean J. Intern. Med."},{"key":"18925_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3904\/kjim.2015.404","volume":"32","author":"HJ Kim","year":"2017","unstructured":"Kim, H. J. et al. Effects of Valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study. Korean J. Intern. Med. 32, 497\u2013504 (2017).","journal-title":"Korean J. Intern. Med."},{"key":"18925_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2165\/11201120-000000000-00000","volume":"9","author":"JE Frampton","year":"2009","unstructured":"Frampton, J. E. & Scott, L. J. Amlodipine\/valsartan single-pill combination: a review of its use in the management of hypertension. Am. J. Cardiovasc. Drugs. 9, 309\u2013330 (2009).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"18925_CR24","doi-asserted-by":"publisher","first-page":"e3084","DOI":"10.1097\/MD.0000000000003084","volume":"95","author":"G Derosa","year":"2016","unstructured":"Derosa, G., Mugellini, A., Pesce, R. M., D\u2019Angelo, A. & Maffioli, P. Olmesartan combined with amlodipine on oxidative stress parameters in type 2 diabetics, compared with single therapies. Med. (Baltim). 95, e3084 (2016).","journal-title":"Med. (Baltim)."},{"key":"18925_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","volume":"148","author":"V Rani","year":"2016","unstructured":"Rani, V., Deep, G., Singh, R. K., Palle, K. & Yadav, U. C. Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies. Life Sci. 148, 183\u2013193 (2016).","journal-title":"Life Sci."},{"key":"18925_CR26","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.25011\/cim.v36i1.19399","volume":"36","author":"E Hopps","year":"2013","unstructured":"Hopps, E. & Caimi, G. Protein oxidation in metabolic syndrome. Clin. Invest. Med. 36, E1\u20138 (2013).","journal-title":"Clin. Invest. Med."},{"key":"18925_CR27","doi-asserted-by":"publisher","first-page":"18828","DOI":"10.3390\/molecules191118828","volume":"19","author":"I Sadowska-Bartosz","year":"2014","unstructured":"Sadowska-Bartosz, I., Galiniak, S. & Bartosz, G. Kinetics of glycoxidation of bovine serum albumin by glucose, Fructose and ribose and its prevention by food components. Molecules 19, 18828\u201318849 (2014).","journal-title":"Molecules"},{"key":"18925_CR28","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.3390\/molecules19044880","volume":"19","author":"I Sadowska-Bartosz","year":"2014","unstructured":"Sadowska-Bartosz, I., Galiniak, S. & Bartosz, G. Kinetics of glycoxidation of bovine serum albumin by Methylglyoxal and Glyoxal and its prevention by various compounds. Molecules 19, 4880\u20134896 (2014).","journal-title":"Molecules"},{"key":"18925_CR29","doi-asserted-by":"crossref","unstructured":"Pawlukianiec, C. et al. A new insight into meloxicam: assessment of antioxidant and Anti-Glycating activity in in vitro studies. Pharmaceuticals (Basel) 13, (2020).","DOI":"10.3390\/ph13090240"},{"key":"18925_CR30","doi-asserted-by":"crossref","unstructured":"Mil, K. M. et al. Pleiotropic Properties of Valsartan: Do They Result from the Antiglycooxidant Activity? Literature Review and In Vitro Study. Oxid. Med. Cell. Longev. 5575545. (2021).","DOI":"10.1155\/2021\/5575545"},{"key":"18925_CR31","doi-asserted-by":"publisher","first-page":"1293295","DOI":"10.3389\/fphar.2023.1293295","volume":"14","author":"M Nesterowicz","year":"2023","unstructured":"Nesterowicz, M. et al. Preliminary evaluation of the antiglycoxidant activity of verapamil using various in vitro and in Silico biochemical\/biophysical methods. Front. Pharmacol. 14, 1293295 (2023).","journal-title":"Front. Pharmacol."},{"key":"18925_CR32","doi-asserted-by":"publisher","first-page":"27559","DOI":"10.1021\/acsomega.4c03025","volume":"9","author":"KK Lauko","year":"2024","unstructured":"Lauko, K. K. et al. Novel properties of old propranololassessment of antiglycation activity through in vitro and in Silico approaches. ACS Omega. 9, 27559\u201327577 (2024).","journal-title":"ACS Omega"},{"key":"18925_CR33","doi-asserted-by":"publisher","first-page":"116632","DOI":"10.1016\/j.biopha.2024.116632","volume":"175","author":"G Biedrzycki","year":"2024","unstructured":"Biedrzycki, G. et al. The antiglycation potential of H1 receptor antagonists \u2013 in vitro studies in bovine serum albumin model and in Silico molecular docking analyses. Biomed. Pharmacother. 175, 116632 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"18925_CR34","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.3390\/ph16091273","volume":"16","author":"G Biedrzycki","year":"2023","unstructured":"Biedrzycki, G. et al. Antioxidant and Anti-Glycation potential of H2 receptor Antagonists\u2014In vitro studies and a systematic literature review. Pharmaceuticals 16, 1273 (2023).","journal-title":"Pharmaceuticals"},{"key":"18925_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70\u201377 (1959).","journal-title":"Arch. Biochem. Biophys."},{"key":"18925_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick, A. Z. & Packer, L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233, 357\u2013363 (1994).","journal-title":"Methods Enzymol."},{"key":"18925_CR37","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00228-007-0378-1","volume":"63","author":"J \u0160krha","year":"2007","unstructured":"\u0160krha, J. et al. Oxidative stress and endothelium influenced by Metformin in type 2 diabetes mellitus. Eur. J. Clin. Pharmacol. 63, 1107\u20131114 (2007).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"18925_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.freeradbiomed.2009.01.007","volume":"46","author":"CL Hawkins","year":"2009","unstructured":"Hawkins, C. L., Morgan, P. E. & Davies, M. J. Quantification of protein modification by oxidants. Free Radic Biol. Med. 46, 965\u2013988 (2009).","journal-title":"Free Radic Biol. Med."},{"key":"18925_CR39","first-page":"233","volume":"6","author":"SD Sharma","year":"2002","unstructured":"Sharma, S. D., Pandey, B. N., Mishra, K. P. & Sivakami, S. Amadori product and age formation during nonenzymatic glycosylation of bovine serum albumin in vitro. J. Biochem. Mol. Biol. Biophys. 6, 233\u2013242 (2002).","journal-title":"J. Biochem. Mol. Biol. Biophys."},{"key":"18925_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"2","author":"H Levine","year":"1993","unstructured":"Levine, H. Thioflavine T interaction with synthetic alzheimer\u2019s disease \u03b2 -amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2, 404\u2013410 (1993).","journal-title":"Protein Sci."},{"key":"18925_CR41","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","volume":"276","author":"SA Hudson","year":"2009","unstructured":"Hudson, S. A., Ecroyd, H., Kee, T. W. & Carver, J. A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 276, 5960\u20135972 (2009).","journal-title":"FEBS J."},{"key":"18925_CR42","doi-asserted-by":"crossref","unstructured":"M\u00fcnch, G. et al. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Clin Chem. Lab. Med.\u00a035, (1997).","DOI":"10.1515\/cclm.1997.35.9.669"},{"key":"18925_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.33549\/physiolres.930234","volume":"51","author":"M Kalousov\u00e1","year":"2002","unstructured":"Kalousov\u00e1, M., Skrha, J. & Zima, T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res. 51, 597\u2013604 (2002).","journal-title":"Physiol. Res."},{"key":"18925_CR44","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.13005\/bpj\/2331","volume":"14","author":"A Sindhuja","year":"2021","unstructured":"Sindhuja, A., Vimalavathini, S. A., Kavimani, S. & R, V. R. & In Silico docking studies of antiglycation activity of Isorhamnetin on molecular proteins of advanced glycation end product (AGE) pathway. Biomed. Pharmacol. J. 14, 2299\u20132306 (2021).","journal-title":"Biomed. Pharmacol. J."},{"key":"18925_CR45","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s43088-020-00068-6","volume":"9","author":"BJ Oso","year":"2020","unstructured":"Oso, B. J. & Olaoye, I. F. Antiglycaemic potentials and molecular docking studies of the extracts of Cassia Alata L. Beni-Suef Univ. J. Basic. Appl. Sci. 9, 43 (2020).","journal-title":"Beni-Suef Univ. J. Basic. Appl. Sci."},{"key":"18925_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/antiox13030339","volume":"13","author":"I Klobu\u010dar","year":"2024","unstructured":"Klobu\u010dar, I. et al. Advanced oxidation protein products are strongly associated with the serum levels and lipid contents of lipoprotein subclasses in healthy volunteers and patients with metabolic syndrome. Antioxidants 13, 339 (2024).","journal-title":"Antioxidants"},{"key":"18925_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12931-016-0471-z","volume":"17","author":"E Zinellu","year":"2016","unstructured":"Zinellu, E., Zinellu, A., Fois, A. G., Carru, C. & Pirina, P. Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic review. Respir Res. 17, 150 (2016).","journal-title":"Respir Res."},{"key":"18925_CR48","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.1038\/s41598-020-65918-w","volume":"10","author":"A Koike","year":"2020","unstructured":"Koike, A. et al. Thiol groups as a biomarker for the diagnosis and prognosis of prostate cancer. Sci. Rep. 10, 9093 (2020).","journal-title":"Sci. Rep."},{"key":"18925_CR49","doi-asserted-by":"publisher","first-page":"117263","DOI":"10.1016\/j.ejmech.2025.117263","volume":"285","author":"C Pawlukianiec","year":"2025","unstructured":"Pawlukianiec, C. et al. A comparative study on the antioxidant and antiglycation properties of different vitamin D forms. Eur. J. Med. Chem. 285, 117263 (2025).","journal-title":"Eur. J. Med. Chem."},{"key":"18925_CR50","doi-asserted-by":"publisher","first-page":"113587","DOI":"10.1016\/j.fct.2022.113587","volume":"172","author":"Y Deng","year":"2023","unstructured":"Deng, Y. et al. Inhibitory effect of Ginkgo Biloba seeds peptides on methylglyoxal-induced glycations. Food Chem. Toxicol. 172, 113587 (2023).","journal-title":"Food Chem. Toxicol."},{"key":"18925_CR51","doi-asserted-by":"publisher","first-page":"9198","DOI":"10.1038\/s41598-024-59876-w","volume":"14","author":"B Wolszczak-Biedrzycka","year":"2024","unstructured":"Wolszczak-Biedrzycka, B. et al. Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19. Sci. Rep. 14, 9198 (2024).","journal-title":"Sci. Rep."},{"key":"18925_CR52","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.freeradbiomed.2014.10.810","volume":"75","author":"I Sadowska-Bartosz","year":"2014","unstructured":"Sadowska-Bartosz, I., Galiniak, S. & Bartosz, G. Polyphenols protect against protein glycoxidation. Free Radic Biol. Med. 75, S47 (2014).","journal-title":"Free Radic Biol. Med."},{"key":"18925_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/14756366.2022.2137161","volume":"38","author":"M Nesterowicz","year":"2023","unstructured":"Nesterowicz, M., \u017bendzian-Piotrowska, M., \u0141adny, J. R., Zalewska, A. & Maciejczyk, M. Antiglycoxidative properties of amantadine \u2013 a systematic review and comprehensive in vitro study. J. Enzyme Inhib. Med. Chem. 38, 138\u2013155 (2023).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"18925_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.redox.2015.06.017","volume":"6","author":"I Sadowska-Bartosz","year":"2015","unstructured":"Sadowska-Bartosz, I., Stefaniuk, I., Galiniak, S. & Bartosz, G. Glycation of bovine serum albumin by ascorbate in vitro: possible contribution of the ascorbyl radical? Redox Biol. 6, 93\u201399 (2015).","journal-title":"Redox Biol."},{"key":"18925_CR55","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61373","author":"D Kothandan","year":"2024","unstructured":"Kothandan, D. et al. Advanced glycation end Products-Induced alzheimer\u2019s disease and its novel therapeutic approaches: A comprehensive review. Cureus https:\/\/doi.org\/10.7759\/cureus.61373 (2024).","journal-title":"Cureus"},{"key":"18925_CR56","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1038\/cddis.2013.180","volume":"4","author":"XH Li","year":"2013","unstructured":"Li, X. H. et al. Glycation exacerbates the neuronal toxicity of \u03b2-amyloid. Cell. Death Dis. 4, e673\u2013e673 (2013).","journal-title":"Cell. Death Dis."},{"key":"18925_CR57","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.3390\/ijms22126609","volume":"22","author":"I Sirangelo","year":"2021","unstructured":"Sirangelo, I. & Iannuzzi, C. Understanding the role of protein glycation in the amyloid aggregation process. Int. J. Mol. Sci. 22, 6609 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"18925_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05051-9","author":"S Ayoub","year":"2025","unstructured":"Ayoub, S. et al. Glycation in alzheimer\u2019s disease and type 2 diabetes: the prospect of dual drug approaches for therapeutic interventions. Mol. Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05051-9 (2025).","journal-title":"Mol. Neurobiol."},{"key":"18925_CR59","doi-asserted-by":"publisher","first-page":"92","DOI":"10.2174\/157339912799424528","volume":"8","author":"A Elosta","year":"2012","unstructured":"Elosta, A., Ghous, T. & Ahmed, N. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications. Curr. Diabetes Rev. 8, 92\u2013108 (2012).","journal-title":"Curr. Diabetes Rev."},{"key":"18925_CR60","doi-asserted-by":"publisher","first-page":"111738","DOI":"10.1016\/j.fct.2020.111738","volume":"145","author":"U Hossain","year":"2020","unstructured":"Hossain, U., Das, A. K., Ghosh, S. & Sil, P. C. An overview on the role of bioactive \u03b1-glucosidase inhibitors in ameliorating diabetic complications. Food Chem. Toxicol. 145, 111738 (2020).","journal-title":"Food Chem. Toxicol."},{"key":"18925_CR61","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.3390\/molecules25235591","volume":"25","author":"CY Shen","year":"2020","unstructured":"Shen, C. Y. et al. The development of Maillard reaction, and advanced glycation end product (AGE)-Receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-Related diseases. Molecules 25, 5591 (2020).","journal-title":"Molecules"},{"key":"18925_CR62","doi-asserted-by":"publisher","first-page":"110655","DOI":"10.1016\/j.biopha.2020.110655","volume":"131","author":"N Pathomthongtaweechai","year":"2020","unstructured":"Pathomthongtaweechai, N. & Chutipongtanate, S. AGE\/RAGE signaling-mediated Endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy. Biomed. Pharmacother. 131, 110655 (2020).","journal-title":"Biomed. Pharmacother"},{"key":"18925_CR63","doi-asserted-by":"crossref","unstructured":"Pasten, C. et al. Aminoguanidine prevents the oxidative stress, inhibiting elements of inflammation, endothelial activation, mesenchymal markers, and confers a renoprotective effect in renal ischemia and reperfusion injury. Antioxidants 10, (2021).","DOI":"10.3390\/antiox10111724"},{"key":"18925_CR64","doi-asserted-by":"crossref","unstructured":"Pedre, B., Barayeu, U., Ezeri\u0146a, D. & Dick, T. P. The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species. Pharmacol Ther 228, (2021).","DOI":"10.1016\/j.pharmthera.2021.107916"},{"key":"18925_CR65","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/acs.est.3c10824","volume":"58","author":"W Qin","year":"2024","unstructured":"Qin, W., Escher, B. I., Huchthausen, J., Fu, Q. & Henneberger, L. Species difference?? Bovine, trout, and human plasma protein binding of Per- and polyfluoroalkyl substances. Environ. Sci. Technol. 58, 9954\u20139966 (2024).","journal-title":"Environ. Sci. Technol."},{"key":"18925_CR66","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijbiomac.2014.11.011","volume":"73","author":"Q Lin","year":"2015","unstructured":"Lin, Q. et al. Protein adsorption behaviors of carboxymethylated bacterial cellulose membranes. Int. J. Biol. Macromol. 73, 264\u2013269 (2015).","journal-title":"Int. J. Biol. Macromol."},{"key":"18925_CR67","doi-asserted-by":"publisher","first-page":"123285","DOI":"10.1016\/j.molliq.2023.123285","volume":"391","author":"N Tran","year":"2023","unstructured":"Tran, N. A comparison of surface properties for bovine serum albumin and human serum albumin \u2013 Dynamic\/equilibrium surface tension and dilational modulus. J. Mol. Liq. 391, 123285 (2023).","journal-title":"J. Mol. Liq"},{"key":"18925_CR68","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1110\/ps.0240003","volume":"12","author":"MS Celej","year":"2003","unstructured":"Celej, M. S., Montich, G. G. & Fidelio, G. D. Protein stability induced by ligand binding correlates with changes in protein flexibility. Protein Sci. 12, 1496\u20131506 (2003).","journal-title":"Protein Sci."},{"key":"18925_CR69","doi-asserted-by":"publisher","first-page":"114288","DOI":"10.1016\/j.colsurfb.2024.114288","volume":"245","author":"S Hou","year":"2025","unstructured":"Hou, S. et al. Construction of BSA-ZnO&Quercetin based multifunctional bionic self-assembly system and their antibacterial mechanism study. Colloids Surf. B Biointerfaces. 245, 114288 (2025).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"18925_CR70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mas.21381","volume":"33","author":"M Fedorova","year":"2014","unstructured":"Fedorova, M., Bollineni, R. C. & Hoffmann, R. Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies. Mass. Spectrom. Rev. 33, 79\u201397 (2014).","journal-title":"Mass. Spectrom. Rev."},{"key":"18925_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2022.11.003","author":"A Shin","year":"2023","unstructured":"Shin, A., Connolly, S. & Kabytaev, K. Protein glycation in diabetes mellitus. Adv. clin. chem. https:\/\/doi.org\/10.1016\/bs.acc.2022.11.003 (2023).","journal-title":"Adv. clin. chem."},{"key":"18925_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12551-024-01188-4","volume":"16","author":"AB Uceda","year":"2024","unstructured":"Uceda, A. B., Mari\u00f1o, L., Casasnovas, R. & Adrover, M. An overview on glycation: molecular mechanisms, impact on proteins, pathogenesis, and Inhibition. Biophys. Rev. 16, 189\u2013218 (2024).","journal-title":"Biophys. Rev."},{"key":"18925_CR73","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1753-0407.12475","volume":"9","author":"SI Yamagishi","year":"2017","unstructured":"Yamagishi, S. I., Nakamura, N. & Matsui, T. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory. J. Diabetes. 9, 141\u2013148 (2017).","journal-title":"J. Diabetes"},{"key":"18925_CR74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom5010194","volume":"5","author":"K Nowotny","year":"2015","unstructured":"Nowotny, K., Jung, T., H\u00f6hn, A., Weber, D. & Grune, T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5, 194\u2013222 (2015).","journal-title":"Biomolecules"},{"key":"18925_CR75","doi-asserted-by":"publisher","first-page":"223","DOI":"10.31083\/j.fbl2906223","volume":"29","author":"H Naderi-Meshkin","year":"2024","unstructured":"Naderi-Meshkin, H. & Setyaningsih, W. A. W. Endothelial cell dysfunction: onset, progression, and consequences. Front. Biosci. (Landmark Ed. 29, 223 (2024).","journal-title":"Front. Biosci. (Landmark Ed."},{"key":"18925_CR76","doi-asserted-by":"publisher","first-page":"173874","DOI":"10.1016\/j.ejphar.2021.173874","volume":"894","author":"H Jahan","year":"2021","unstructured":"Jahan, H. & Choudhary, M. I. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE\/TLR4-reactive oxygen species-activated NF-k\u03b2 nexus. Eur. J. Pharmacol. 894, 173874 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"18925_CR77","doi-asserted-by":"publisher","first-page":"e00038","DOI":"10.1097\/IN9.0000000000000038","volume":"6","author":"V Kruglov","year":"2024","unstructured":"Kruglov, V., Jang, I. H. & Camell, C. D. Inflammaging and fatty acid oxidation in monocytes and macrophages. Immunometabolism (Cobham Surrey). 6, e00038 (2024).","journal-title":"Immunometabolism (Cobham Surrey)"},{"key":"18925_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2017.05.005","volume":"100","author":"MA Incalza","year":"2018","unstructured":"Incalza, M. A. et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 100, 1\u201319 (2018).","journal-title":"Vascul Pharmacol."},{"key":"18925_CR79","first-page":"1505","volume":"147","author":"D P\u00e1ll","year":"2006","unstructured":"P\u00e1ll, D., Katona, E., Juh\u00e1sz, M. & Paragh, G. Prevention of target organ damage with modern antihypertensive agents. Orv Hetil. 147, 1505\u20131511 (2006).","journal-title":"Orv Hetil"},{"key":"18925_CR80","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3109\/10715762.2013.814126","volume":"47","author":"CO Soares","year":"2013","unstructured":"Soares, C. O., Boiani, M., Marnett, L. J. & Bechara, E. J. H. Cytotoxicity of 1,4-diamino-2-butanone, a Putrescine analogue, to RKO cells: mechanism and redox imbalance. Free Radic Res. 47, 672\u2013682 (2013).","journal-title":"Free Radic Res."},{"key":"18925_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiae215","author":"D Prantner","year":"2024","unstructured":"Prantner, D. & Vogel, S. N. Intracellular Methylglyoxal accumulation in classically activated mouse macrophages is mediated by HIF-1\u03b1. J. Leukoc. Biol. https:\/\/doi.org\/10.1093\/jleuko\/qiae215 (2024).","journal-title":"J. Leukoc. Biol."},{"key":"18925_CR82","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jconrel.2023.09.026","volume":"363","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Controlled extracellular vesicles release from aminoguanidine nanoparticle-loaded polylysine hydrogel for synergistic treatment of spinal cord injury. J. Control Release. 363, 27\u201342 (2023).","journal-title":"J. Control Release"},{"key":"18925_CR83","doi-asserted-by":"publisher","first-page":"101329","DOI":"10.1016\/j.genrep.2021.101329","volume":"25","author":"A Najafi","year":"2021","unstructured":"Najafi, A., Behnam, B., Jafari, E., Anani, H. & Karami-Mohajeri, S. Aminoguanidine induced apoptosis in human hepatocarcinoma HepG2 cells. Gene Rep. 25, 101329 (2021).","journal-title":"Gene Rep."},{"key":"18925_CR84","unstructured":"Bulsara, K. G., Patel, P. & Cassagnol, M. Amlodipine. StatPearls (2024)."},{"key":"18925_CR85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/01.HYP.34.2.273","volume":"34","author":"Y Nakamura","year":"1999","unstructured":"Nakamura, Y., Ono, H. & Frohlich, E. D. Differential effects of T- and L-Type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. Hypertension 34, 273\u2013278 (1999).","journal-title":"Hypertension"},{"key":"18925_CR86","doi-asserted-by":"publisher","first-page":"e24752","DOI":"10.1002\/jcla.24752","volume":"36","author":"H Darvishi-Khezri","year":"2022","unstructured":"Darvishi-Khezri, H. et al. Amlodipine: can act as an antioxidant in patients with transfusion-dependent \u03b2-thalassemia? A double-blind, controlled, crossover trial. J. Clin. Lab. Anal. 36, e24752 (2022).","journal-title":"J. Clin. Lab. Anal."},{"key":"18925_CR87","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0006-2952(95)02162-0","volume":"51","author":"N Rojstaczer","year":"1996","unstructured":"Rojstaczer, N. & Triggle, D. J. Structure-function relationships of calcium antagonists. Biochem. Pharmacol. 51, 141\u2013150 (1996).","journal-title":"Biochem. Pharmacol."},{"key":"18925_CR88","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40360-023-00722-6","volume":"24","author":"H Shirzad","year":"2023","unstructured":"Shirzad, H., Mousavinezhad, S. A., Panji, M. & Ala, M. Amlodipine alleviates renal ischemia\/reperfusion injury in rats through Nrf2\/Sestrin2\/PGC-1\u03b1\/TFAM pathway. BMC Pharmacol. Toxicol. 24, 82 (2023).","journal-title":"BMC Pharmacol. Toxicol."},{"key":"18925_CR89","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1291\/hypres.27.271","volume":"27","author":"K Yamagata","year":"2004","unstructured":"Yamagata, K., Ichinose, S. & Tagami, M. Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens. Res. 27, 271\u2013282 (2004).","journal-title":"Hypertens. Res."},{"key":"18925_CR90","first-page":"89","volume":"20","author":"K Hongo","year":"2010","unstructured":"Hongo, K. & Yoshimura, M. Calcium antagonists: current and future applications based on new evidence. Cardio-protective effect of calcium antagonists. Clin. Calcium. 20, 89\u201393 (2010).","journal-title":"Clin. Calcium"},{"key":"18925_CR91","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/sj.ki.5001983","volume":"70","author":"S Aslam","year":"2006","unstructured":"Aslam, S., Santha, T., Leone, A. & Wilcox, C. Effects of amlodipine and Valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on Hemodialysis. Kidney Int. 70, 2109\u20132115 (2006).","journal-title":"Kidney Int."},{"key":"18925_CR92","doi-asserted-by":"publisher","first-page":"166044","DOI":"10.1016\/j.bbadis.2020.166044","volume":"1867","author":"I Tuleta","year":"2021","unstructured":"Tuleta, I. & Frangogiannis, N. G. Diabetic fibrosis. Biochim. Biophys. Acta - Mol. Basis Dis. 1867, 166044 (2021).","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"18925_CR93","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","volume":"24","author":"P Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez, P., Lozano, P., Ros, G. & Solano, F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int. J. Mol. Sci. 24, 9352 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"18925_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.09.029","author":"Z Yao","year":"2024","unstructured":"Yao, Z. et al. The role of JNK signaling pathway in organ fibrosis. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2024.09.029 (2024).","journal-title":"J. Adv. Res."},{"key":"18925_CR95","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1248\/bpb.29.75","volume":"29","author":"K Akira","year":"2006","unstructured":"Akira, K., Amano, M., Okajima, F., Hashimoto, T. & Oikawa, S. Inhibitory effects of amlodipine and Fluvastatin on the deposition of advanced glycation end products in aortic wall of cholesterol and Fructose-Fed rabbits. Biol. Pharm. Bull. 29, 75\u201381 (2006).","journal-title":"Biol. Pharm. Bull."},{"key":"18925_CR96","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/clc.20885","volume":"34","author":"T Nakamura","year":"2011","unstructured":"Nakamura, T. et al. Calcium channel blocker Inhibition of AGE and RAGE axis limits renal injury in nondiabetic patients with stage I or II chronic kidney disease. Clin. Cardiol. 34, 372\u2013377 (2011).","journal-title":"Clin. Cardiol."},{"key":"18925_CR97","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1291\/hypres.29.457","volume":"29","author":"T Yoshii","year":"2006","unstructured":"Yoshii, T. et al. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens. Res. 29, 457\u2013466 (2006).","journal-title":"Hypertens. Res."},{"key":"18925_CR98","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1097\/HJH.0000000000002145","volume":"37","author":"D Vukadinovi\u0107","year":"2019","unstructured":"Vukadinovi\u0107, D. et al. Peripheral edema and headache associated with amlodipine treatment. J. Hypertens. 37, 2093\u20132103 (2019).","journal-title":"J. Hypertens."},{"key":"18925_CR99","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/10408399209527575","volume":"31","author":"CJ Rumney","year":"1992","unstructured":"Rumney, C. J. & Rowland, I. R. In vivo and in vitro models of the human colonic flora. Crit. Rev. Food Sci. Nutr. 31, 299\u2013331 (1992).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"18925_CR100","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acs.molpharmaceut.3c00195","volume":"20","author":"I De Hoon","year":"2023","unstructured":"De Hoon, I., Boukherroub, R., De Smedt, S. C., Szunerits, S. & Sauvage, F. In vitro and ex vivo models for assessing drug permeation across the cornea. Mol. Pharm. 20, 3298\u20133319 (2023).","journal-title":"Mol. Pharm."},{"key":"18925_CR101","doi-asserted-by":"crossref","unstructured":"Guiselin, T., Lecoutey, C., Rochais, C. & Dallemagne, P. Conceptual framework of the design of pleiotropic drugs against alzheimer\u2019s disease. Pharmaceutics 15, (2023).","DOI":"10.3390\/pharmaceutics15102382"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18925-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18925-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18925-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T12:03:08Z","timestamp":1758888188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18925-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18925"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18925-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"23 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33277"}}